| Market Cap | 718M 629M 584M 536M 1.01B 69.25B 1.03B 6.95B 2.72B 33.89B 2.69B 2.64B 117B | P/E 2026 * |
11.4x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 448M 392M 364M 335M 630M 43.19B 640M 4.34B 1.7B 21.13B 1.68B 1.64B 73B | EV / Sales 2026 * |
3.07x | EV / Sales 2027 * | 2.05x |
| Free-Float |
96.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: KemPharm, Inc.
| 1 day | -4.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil McFarlane
CEO | Chief Executive Officer | 53 | 10/10/2023 |
Justin Renz
DFI | Director of Finance/CFO | 54 | 09/03/2026 |
Rahsaan Thompson
CMP | Compliance Officer | 55 | 25/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tamara Favorito
CHM | Chairman | 67 | 08/05/2023 |
Douglas Calder
BRD | Director/Board Member | 59 | 25/04/2023 |
Corey Watton
BRD | Director/Board Member | 56 | 25/04/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.32% | +29.70% | - | - | 718M | |
| +0.96% | +3.12% | +56.19% | +15.47% | 315B | |
| -1.26% | -1.88% | +20.53% | -14.09% | 67.93B | |
| -0.99% | +2.64% | +35.25% | +81.44% | 9.23B | |
| -1.26% | -1.95% | +2.83% | -4.98% | 8.43B | |
| -1.03% | -1.79% | -24.11% | -10.07% | 4.07B | |
| +0.38% | -9.58% | -5.58% | +22.13% | 3.77B | |
| +0.86% | +1.01% | -43.84% | +10.01% | 3.54B | |
| -1.94% | -1.66% | +43.68% | +53.35% | 2.72B | |
| -2.81% | -6.33% | +5.13% | -9.94% | 2.13B | |
| Average | -1.14% | -0.91% | +10.01% | +15.92% | 46.3B | |
| Weighted average by Cap. | +0.43% | +3.04% | +46.30% | +11.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 146M 128M 119M 109M 205M 14.06B 208M 1.41B 553M 6.88B 547M 535M 23.77B | 182M 160M 148M 136M 257M 17.59B 260M 1.77B 691M 8.6B 684M 669M 29.73B |
| Net income | 65.31M 57.22M 53.12M 48.81M 91.98M 6.3B 93.33M 633M 248M 3.08B 245M 240M 10.65B | 62.32M 54.61M 50.7M 46.58M 87.78M 6.01B 89.07M 604M 236M 2.94B 234M 229M 10.17B |
| Net Debt | -270M -237M -220M -202M -380M -26.06B -386M -2.62B -1.02B -12.75B -1.01B -992M -44.06B | -345M -302M -281M -258M -486M -33.28B -493M -3.34B -1.31B -16.28B -1.29B -1.27B -56.26B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
